Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Mechanisms, treatment and prevention of cellular injury and death from delayed events after aneurysmal subarachnoid hemorrhage.

Wan H, AlHarbi BM, Macdonald RL.

Expert Opin Pharmacother. 2014 Feb;15(2):231-43. doi: 10.1517/14656566.2014.865724. Epub 2013 Nov 27. Review.

PMID:
24283706
2.

Early brain injury following aneurysmal subarachnoid hemorrhage: emphasis on cellular apoptosis.

Yuksel S, Tosun YB, Cahill J, Solaroglu I.

Turk Neurosurg. 2012;22(5):529-33. doi: 10.5137/1019-5149.JTN.5731-12.1. Review.

3.

New therapeutic approaches to subarachnoid hemorrhage.

Barry C, Turner RJ, Corrigan F, Vink R.

Expert Opin Investig Drugs. 2012 Jun;21(6):845-59. doi: 10.1517/13543784.2012.683113. Epub 2012 Apr 25. Review.

PMID:
22530758
4.

Aneurysmal subarachnoid hemorrhage: pathobiology, current treatment and future directions.

Serrone JC, Maekawa H, Tjahjadi M, Hernesniemi J.

Expert Rev Neurother. 2015 Apr;15(4):367-80. doi: 10.1586/14737175.2015.1018892. Epub 2015 Feb 26. Review.

PMID:
25719927
5.
6.

Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage.

Kramer AH, Gurka MJ, Nathan B, Dumont AS, Kassell NF, Bleck TP.

Neurosurgery. 2008 Feb;62(2):422-7; discussion 427-30. doi: 10.1227/01.neu.0000316009.19012.e3.

PMID:
18382320
7.

Preadmission statin use does not improve functional outcomes or prevent delayed ischemic events in patients with spontaneous subarachnoid hemorrhage.

Lizza BD, Kosteva A, Maas MB, Rosenberg NF, Liotta E, Guth J, Levasseur-Franklin KE, Naidech AM.

Pharmacotherapy. 2014 Aug;34(8):811-7. doi: 10.1002/phar.1436. Epub 2014 May 7.

PMID:
24807391
8.

Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia.

Vergouwen MD, Vermeulen M, Coert BA, Stroes ES, Roos YB.

J Cereb Blood Flow Metab. 2008 Nov;28(11):1761-70. doi: 10.1038/jcbfm.2008.74. Epub 2008 Jul 16. Review.

PMID:
18628782
9.

Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury.

Sehba FA, Pluta RM, Zhang JH.

Mol Neurobiol. 2011 Feb;43(1):27-40. doi: 10.1007/s12035-010-8155-z. Epub 2010 Dec 15. Review.

10.

Management of delayed cerebral ischemia after subarachnoid hemorrhage.

Koenig MA.

Continuum (Minneap Minn). 2012 Jun;18(3):579-97. doi: 10.1212/01.CON.0000415429.99394.e8. Review.

PMID:
22810250
11.

Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis.

Sillberg VA, Wells GA, Perry JJ.

Stroke. 2008 Sep;39(9):2622-6. doi: 10.1161/STROKEAHA.107.508341. Epub 2008 Jul 24.

12.

Molecular mechanisms of early brain injury after subarachnoid hemorrhage.

Ostrowski RP, Colohan AR, Zhang JH.

Neurol Res. 2006 Jun;28(4):399-414. Review.

PMID:
16759443
14.

Mechanisms of early brain injury after subarachnoid hemorrhage.

Cahill J, Calvert JW, Zhang JH.

J Cereb Blood Flow Metab. 2006 Nov;26(11):1341-53. Epub 2006 Feb 15. Review. Erratum in: J Cereb Blood Flow Metab. 2006 Nov;26(11):1463. Cahill, W Julian [corrected to Cahill, Julian]; Calvert, John H [corrected to Calvert, John W].

PMID:
16482081
15.

Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ("triple-H" therapy) after subarachnoid hemorrhage.

Origitano TC, Wascher TM, Reichman OH, Anderson DE.

Neurosurgery. 1990 Nov;27(5):729-39; discussion 739-40.

PMID:
2259403
17.

Aneurysmal subarachnoid hemorrhage: an overview for the practicing neurologist.

Dupont SA, Wijdicks EF, Lanzino G, Rabinstein AA.

Semin Neurol. 2010 Nov;30(5):545-54. doi: 10.1055/s-0030-1268862. Epub 2011 Jan 4. Review.

PMID:
21207347
18.

[Perspectives in the treatment of subarachnoid-hemorrhage-induced cerebral vasospasm].

Fandino J, Fathi AR, Graupner T, Jacob S, Landolt H.

Neurocirugia (Astur). 2007 Feb;18(1):16-27. Review. Spanish.

19.

The roles of early brain injury in cerebral vasospasm following subarachnoid hemorrhage: from clinical and scientific aspects.

Nishizawa S.

Acta Neurochir Suppl. 2013;115:207-11. doi: 10.1007/978-3-7091-1192-5_38. Review.

PMID:
22890670
20.

Delayed administration of the K+ channel activator cromakalim attenuates cerebral vasospasm after experimental subarachnoid hemorrhage.

Kwan AL, Lin CL, Wu CS, Chen EF, Howng SL, Kassell NF, Lee KS.

Acta Neurochir (Wien). 2000;142(2):193-7.

PMID:
10795894

Supplemental Content

Support Center